Halozyme Therapeutics Inc (HALO)

[biotechinvestor1]

This is what I care about:

“SVB Leerink Sets Halozyme Therapeutics
FY2027 Earnings Estimates at $7.51 EPS.”

It means that Halozyme’s earnings will grow 3 folds in the next 4 years. If you put a conservative PE ratio of 20 (very conservative for a fast growing company like Halo), you will have a $140 share price for 2027.

This is why all the dips are a blessing. Fundamentals dictate that over the next 4 years, we are headed to $140. I have and will load more every time the train has a stop. Been doing it since halo was in low teens (go back and see my posts)